Auxilium Pharmaceuticals Inc

Type: Company
Name: Auxilium Pharmaceuticals Inc
Nationality: United States
Web Address: http://www.auxilium.com/
First reported 12 hours ago - Updated 12 hours ago - 1 reports

US FDA approves Stendra for erectile dysfunction treatment

VIVUS, Inc., a biopharmaceutical company, and Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, announced that the US Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for ... [Published PharmaBiz - 12 hours ago]
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

BioSpecifics Technologies Corp. to Present at the 21st Annual BioCentury NewsMakers in the Biotech Industry Conference

About BioSpecifics Technologies Corp. BioSpecifics Technologies Corp. is a biopharmaceutical company that has developed injectable collagenase for twelve clinical indications to date. Injectable collagenase is approved for marketing as XIAFLEX® (collagenase ... [Published Industrial Info Financials - Sep 19 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

3 Biotechs Investors Should Watch

In the heathcare version of "Where the Money Is", guest joins regulars Michael Douglass and David Williamson to discuss the state of the healthcare sector.In M&A news, Endo International has made an unsolicited bid to acquire Auxilium Pharmaceuticals ... [Published Motley Fool - Sep 19 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

ED drug Stendra gets FDA approval, one-ups Viagra

Things are looking up for erectile dysfunction patients in the US, for the FDA has approved a new drug called Stendra which clinical studies have proven can work in just 15 minutes before sexual intercourse, giving it the upper hand over go-to treatment ... [Published Yahoo Philippines News - Sep 19 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

Benzinga's Top Downgrades

Analysts at Deutsche Bank downgraded Oracle (NYSE: ORCL) from Buy to Hold. The target price for Oracle has been lowered from $48 to $42. Oracle's shares closed at $41.55 yesterday.William Blair downgraded Concur Technologies (NASDAQ: CNQR) from Outperform ... [Published Benzinga.com - Sep 19 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 2 reports

UBS Downgrades Auxilium Pharmaceuticals To Neutral

Analysts at UBS downgraded Auxilium Pharmaceuticals (NASDAQ: AUXL[1]) from Buy to Neutral. Auxilium Pharmaceuticals shares have jumped 64.74% over the past 52 weeks, while the S&P 500 index has surged 17.63% in the same period.Auxilium Pharma's shares ... [Published DailyMe.Com - Sep 19 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 11 reports

FDA Expands Labeling for Fast-Acting Erectile Dysfunction Drug, Stendra (Avanafil)

Treatment administered within 15 minutes of sexual activityThe FDA has approved a supplemental new drug application (sNDA) for Stendra (avanafil, Vivus, Inc./Auxilium Pharmaceuticals). Stendra is now the only FDA-approved erectile dysfunction (ED) medication ... [Published PT Community - Sep 18 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 6 reports

Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting

CHESTERBROOK, Pa.DC is a progressive hand disease that can present with multiple collagen "cords" that limit finger movement. It is estimated that 35 to 40 percent of annual surgical procedures in the U.S. are performed to treat more than one DC cord ... [Published Bio-Medicine - Sep 18 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 4 reports

Endo's Bid For Auxilium Makes Sense

By Stephen Simpson, CFA :Endo International (NASDAQ: ENDP ) has been very acquisitive over the past couple of years, using deals to not only leverage its tax-advantaged Irish domicile but bulk up what I believe is an underrated generics business. Tuesday's ... [Published BioPortfolio - Sep 18 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 1 reports

Markets open higher as Fed maintains rates

The markets opened higher with the Dow climbing 77 points to 17,233 after the Federal Reserve maintained interest rates. Nasdaq gained 20 points to 4,582.On the upsideThe Food and Drug Administration approved the fast-acting erectile dysfunction medication ... [Published WGNT - Sep 18 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 1 reports

Short Interest: Empire Resorts (NYNY), Net Element (NETE), Auxilium Pharmaceuticals (AUXL), Outerwall (OUTR), Pandora Media (P)

Recent short interest data for the 8/29/2014 settlement date shows an increase in short interest for shares of Empire Resorts Inc. (NYNY). As of August 29, the short interest for the gaming and entertainment company totaled 1,606,526 shares, as compared ... [Published Wall Street Pit - Sep 18 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 1 reports

Vivus And Auxilium Pharma Say FDA Approves SNDA For Stendra - Quick Facts

Vivus Inc. (VVUS: Quote) and Auxilium Pharmaceuticals, Inc. (AUXL: Quote) announced that the U.S. Food and Drug Administration or FDA has approved a supplemental new drug application or sNDA for Stendra (avanafil).The companies said that STENDRA is now ... [Published RTTNews.com - Sep 18 2014]

Quotes

The sNDA filed by VIVUS was based on results from Study TA-501 entitled, "A Randomized, Double-Blind, Placebo-Controlled Evaluation of Avanafil for On-Demand Treatment of Men with Erectile Dysfunction." The study was designed to assess the efficacy of two dosage strengths of Stendra as early as approximately 15 minutes after dosing...
The Williams Act was passed in 1968 to deal with hostile acquisitions by conglomerates. The Act deals with "trading by persons in possession of material, nonpublic information relating to a tender offer." In an earlier article , I had said that the Williams Act used the term "tender offer" instead of "acquisition offer" because connotations had changed...
...is engaged in developing, manufacturing, marketing and distributing branded pharmaceutical and generic products as well as medical devices. "We expect that Endo's leading presence in men's health, combined with our R&D capabilities and considerable financial resources will accelerate the growth of XIAFLEX and Auxilium's other products" Endo's Chief Executive Rajiv De Silva said
...Auxilium CEO Adrian Adams said "we believe this label expansion helps position Stendra as an exciting 'on demand' ED treatment."

More Content

All (396) | News (312) | Reports (0) | Blogs (70) | Audio/Video (0) | Fact Sheets (0) | Press Releases (14)
sort by: Date | Relevance
US FDA approves Stendra for erectile dysfunctio... [Published PharmaBiz - 12 hours ago]
VIVUS and Auxilium Announce Stendra Label Expan... [Published Zacks.com - 22 hours ago]
3 Biotechs Investors Should Watch [Published Motley Fool - Sep 19 2014]
ED drug Stendra gets FDA approval, one-ups Viagra [Published Yahoo Philippines News - Sep 19 2014]
Shares of AUXL Up 53.3% Since Uptrend Call on S... [Published Individual.com - Sep 19 2014]
Allergan And Valeant: Lessons From The Go-Go Years [Published Seeking Alpha - Sep 19 2014]
Vivus and Auxilium’s Stendra ED drug approved a... [Published Pharma Letter - Sep 19 2014]
UBS Downgrades Auxilium Pharmaceuticals To Neutral [Published DailyMe.Com - Sep 19 2014]
Top Analyst Upgrades and Downgrades: Alibaba, A... [Published 24/7 Wall St - Sep 19 2014]
Benzinga's Top Downgrades [Published Benzinga.com - Sep 19 2014]
BioSpecifics Technologies Corp. to Present at t... [Published Industrial Info Financials - Sep 19 2014]
BioSpecifics Technologies : to Present at the 2... [Published 4 Traders - Sep 19 2014]
It's Time To Cross The T's... [Published RTTNews.com - Sep 19 2014]
Auxilium Pharmaceuticals Downgraded by Goldman ... [Published American Banking News - Sep 19 2014]
FDA Expands Labeling for Fast-Acting Erectile D... [Published PT Community - Sep 18 2014]
FDA OKs ED Drug Avanafil for Use 15 Minutes Bef... [Published General Medicine eJournal - Sep 18 2014]
FDA OKs fast-action erectile dysfunction drug S... [Published Pharma Times - Sep 18 2014]
Erectile disfunction drug gets approval for use... [Published Philadelphia Business Journal - Sep 18 2014]
Healthcare Review: Echo Therapeutics, Rewalk Ro... [Published BioMedReports - Sep 18 2014]
Endo's Bid For Auxilium Makes Sense [Published BioPortfolio - Sep 18 2014]
Biggest Movers in Healthcare Stocks Now – RDY S... [Published InvestorPlace.com - Sep 18 2014]
Why VIVUS, Inc. Is Today's Best Biotech Stock [Published Motley Fool Discussion Boards - Sep 18 2014]
FDA approves Vivus' ED treatment [Published Chicago Daily Herald - Sep 18 2014]
Mid-Day ETF Update: ETFs, Stocks Higher on Upbe... [Published Nasdaq - Sep 18 2014]
UPDATE 1-Faster-acting erectile dysfunction dru... [Published CNBC - Sep 18 2014]
FDA Approves sNDA for Oral Erectile Dysfunction... [Published Pharmacy Times - Sep 18 2014]
Vivus, Inc. Opens Sharply Higher On ED Drug Mar... [Published Yahoo! Finance - Sep 18 2014]
Update: Auxilium Could Be Acquired By Endo, Wha... [Published Seeking Alpha - Sep 18 2014]
Endo's Bid For Auxilium Makes Sense [Published Seeking Alpha - Sep 18 2014]
VIVUS Inc. (VVUS) Shares Spike Following FDA Ap... [Published Wall Street Pit - Sep 18 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Drug Stock Goes Bananas After Approval Of Its F... [Published Clusterstock - Sep 18 2014]
Shares of pharmaceutical company VIVUS were up as much as 12% on Thursday after the company announced FDA approval for its erectile dysfunction treatment.  The company's drug, STENDRA, is now, "only FDA-approved erectile dysfunction (ED) medication ...
Auxilium Pharmaceuticals, Inc. Presents XIAFLEX... [Published PR Newswire: Health - Sep 18 2014]
CHESTERBROOK, Pa., Sept. 18, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced the first presentation of positive safety and efficacy data from the AUX-CC-867 MULTICORD (MULtiple ...
VIVUS and Auxilium Announce FDA Approval of STE... [Published Marketwire - Breaking News Releases - Sep 18 2014]
MOUNTAIN VIEW, CA and CHESTERBROOK, PA--(Marketwired - September 18, 2014) -   VIVUS, Inc. (NASDAQ: VVUS) and Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental ...
VIVUS And Auxilium Announce FDA Approval Of STE... [Published PR Newswire: Policy & Public Interest - Sep 18 2014]
MOUNTAIN VIEW, Calif. and CHESTERBROOK, Pa., Sept. 18, 2014 /PRNewswire/ -- VIVUS, Inc. (Nasdaq: VVUS) and Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug ...
BioNews [9.17.14] [Published eClinical Trends - Sep 17 2014]
Top News HeadlineCompanyType Jaguar Animal Health, Inc. Files Eighth Investigational New Animal Drug Application Jaguar Animal Health, Inc.Animal Drug Application Gilead's oncology contender comes up short in pancreatic cancer Gilead S ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
Critical Alerts For GT Advanced Technologies, I... [Published Financial Services - Sep 18 2014]
QLT Provides Update on Merger With Auxilium Pha... [Published GlobeNewswire: Acquisitions News - Sep 17 2014]
Auxilium Responds To Unsolicited Proposal From ... [Published Financial Services - Sep 17 2014]
Endo Delivers A Proposal To Acquire Auxilium Ph... [Published Financial Services - Sep 16 2014]
Lifshitz & Miller Law Firm Announces Investigat... [Published Financial Services - Jul 04 2014]
1 2 3
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.